Finally, the accuracy of predicting OS and TTCR in mCRPC patients who progress from mHSPC, classified by tumor burden according to the CHAARTED criteria25, was confirmed to be improved by subdividing by AST/ALT ratio. This evidence concerns the gene GOT1 and neoplasm.